Nanjing Pharmaceutical Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Nanjing Pharmaceutical Co.,Ltd.. Fundamentals are ordered by how Nanjing Pharmaceutical Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Cash outflows from operating activities13,047,925,2931.89067132015-06-30historic
Other current liabilities1,621,616,7250.23498162015-06-30historic
Accounts payable4,087,104,7990.59223182015-06-30historic
Total cost of goods sold11,853,563,9431.71761182015-06-30historic
Revenue11,987,686,0771.73704182015-06-30historic
Cash inflows from operating activities12,944,602,3461.8757192015-06-30historic
Cash from issuing bonds1,600,000,0000.23184242015-06-30historic
Notes receivable923,346,3540.13379282015-06-30historic
Cash paid for other financing activities786,714,2730.114322015-06-30historic
Cash from minority shareholders of subsidiaries30,500,0000.00442442015-06-30historic
Short term borrowings2,668,120,0000.38662782015-06-30historic
Comprehensive income attributable to minority shareholders22,105,5960.0032882015-06-30historic
Non-operating loss6,445,7469.3E-4922015-06-30historic
Minority interests gain21,153,8730.00307922015-06-30historic
Cash inflows from financing activities3,795,206,2380.54993922015-06-30historic
Deferred tax assets115,165,9370.01669972015-06-30historic
Selling expenses233,447,1570.03383972015-06-30historic
Other receivables276,060,8570.041022015-06-30historic
Financial expenses117,989,2250.01711052015-06-30historic
Prepayment427,126,1740.061891072015-06-30historic
Total liabilities9,954,819,5881.442481242015-06-30historic
Other payables535,103,1970.077541262015-06-30historic
Net cash and cash equivalents ending balance1,450,159,2980.210131382015-06-30historic
Total liabilities and equity12,514,419,6991.813371472015-06-30historic
Inventories1,827,094,5100.264751562015-06-30historic
Payroll payable68,273,7860.009891562015-06-30historic
Disposal of fixed assets and others3,052,6604.4E-41562015-06-30historic
Interests payable22,722,7780.003291612015-06-30historic
Estimated liabilities6,622,3719.6E-41762015-06-30historic
Investment income from associate and joint venture5,066,5407.3E-41762015-06-30historic
Cash paid for taxes184,723,4950.026771842015-06-30historic
Minority interest335,066,8780.048551852015-06-30historic
Net change in cash250,821,7180.036342052015-06-30historic
Construction materials240,8863.0E-52192015-06-30historic
Net cashflow from financing activities391,758,3200.056772452015-06-30historic
Operating profit145,983,6800.021152522015-06-30historic
Cash paid for dividends, profits or interests111,316,6450.016132822015-06-30historic
Total profit141,276,2140.020472992015-06-30historic
Net income101,688,8770.014733572015-06-30historic
Total comprehensive income105,417,9850.015283632015-06-30historic
Capital reserve1,083,949,4090.157073642015-06-30historic
Long term equity investment68,226,3550.009893992015-06-30historic
Intangible assets182,903,7840.02654142015-06-30historic
Proceeds from sell of investment8,722,7660.001264722015-06-30historic
Net cash flows from investing activities-37,613,655-0.005455232015-06-30historic
Goodwill3,073,1374.5E-45772015-06-30historic
Purchases of fixed assets and others51,769,3580.00756152015-06-30historic
Other current assets26,077,5810.003786482015-06-30historic
Total non-current assets1,252,272,7100.181466702015-06-30historic
Fixed assets450,150,1000.065237282015-06-30historic
Diluted eps00.011082015-06-30historic